AstraZeneca Research Collaboration Meeting

David Waugh (Participant)

Activity: Other activity typesHosting a delegation or group


Invited participant to advise and run the clinical development of CXCR2 inhibitors in castrate-resistant prostate cancer through academic consortia with Prof Johann de Bono (Royal Marsden Hospital) and Prof Alessandro Alimonti (Lugano, Switzerland). Teleconferences will agree trial protocol, external funding, patient recruitment etc.
Period17 Sep 2015
Held atAstraZeneca Plc, United Kingdom